Oncotarget

Vol 9, No 11

February 9, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 11 of Oncotarget features Figure 4, "Schematic of TAM pathway signaling in innate immune cells," from Wang, et al.

Table of Contents

Research Papers: Gerotarget (Focus on Aging)

Effect of the diet type and temperature on the C. elegans transcriptome

Effect of the diet type and temperature on the C. elegans transcriptome

https://doi.org/10.18632/oncotarget.23563

Eva Gomez-Orte, Eric Cornes, Angelina Zheleva, Beatriz Sáenz-Narciso, María de Toro, María Iñiguez, Rosario Lopez, Juan-Félix San-Juan, Begoña Ezcurra, Begoña Sacristán, Adolfo Sánchez-Blanco, Julián Cerón,  and Juan Cabello
9556-9571
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Age-related changes in expression and signaling of TAM receptor inflammatory regulators in monocytes

Age-related changes in expression and signaling of TAM receptor inflammatory regulators in monocytes

https://doi.org/10.18632/oncotarget.23851

Xiaomei Wang, Anna Malawista, Feng Qian, Christine Ramsey, Heather G. Allore,  and Ruth R. Montgomery
9572-9580
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans

CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans

https://doi.org/10.18632/oncotarget.24039

Yujie Li, Sandra Finkbeiner, Athina Ganner, Julia Gerber, Marinella Klein, Manuel Grafe, Jakob Kandzia, Antje Thien, Kathrin Thedieck, Gerhard Breves, Thomas Jank, Ralf Baumeister, Gerd Walz,  and Elke Neumann- Haefelin
9581-9595
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers: Immunology

Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity

Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity

https://doi.org/10.18632/oncotarget.24073

Xiaofeng Liu, Mi Zhou, Yanling Yang, Jing wu,  and Qisheng Peng
9596-9607
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents

SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents

https://doi.org/10.18632/oncotarget.20033

Jean Davidson, Zhewei Shen, Xue Gong,  and Jonathan R. Pollack
9608-9617
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage

Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage

https://doi.org/10.18632/oncotarget.22709

Macarena Guijo, María Ceballos-Chávez, Elena Gómez-Marín, Laura Basurto-Cayuela,  and José C. Reyes
9618-9631
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

NFAT-mediated defects in erythropoiesis cause anemia in Il2−/− mice

NFAT-mediated defects in erythropoiesis cause anemia in Il2−/− mice

https://doi.org/10.18632/oncotarget.23745

Sabrina Giampaolo, Gabriela Wójcik, Stefan Klein-Hessling, Edgar Serfling,  and Amiya K. Patra
9632-9644
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Molecular characterization of breast cancer cell response to metabolic drugs

Molecular characterization of breast cancer cell response to metabolic drugs

https://doi.org/10.18632/oncotarget.24047

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M. Arevalillo, Mariana Díaz-Almirón, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Hilario Navarro, Rosa Aras-López, Irene Dapía, Rocío López-Vacas, Paolo Nanni, Sara Llorente-Armijo, Pedro Arias, Alberto M. Borobia, Paloma Maín, Jaime Feliú, Enrique Espinosa,  and Juan Ángel Fresno Vara
9645-9660
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression

https://doi.org/10.18632/oncotarget.23800

Domenico Trombetta, Paolo Graziano, Aldo Scarpa, Angelo Sparaneo, Guilio Rossi, Antonio Rossi, Massimo Di Maio, Davide Antonello, Andrea Mafficini, Federico Pio Fabrizio, Maria Carmina Manzorra, Teresa Balsamo, Flavia Centra, Michele Simbolo, Angela Pantalone, Michela Notarangelo, Paola Parente, Maria Cecilia Lucia Dimitri, Antonio Bonfitto, Fabiola Fiordelisi, Clelia Tiziana Storlazzi, Alberto L'Abbate, Marco Taurchini, Evaristo Maiello, Vito Michele Fazio,  and Lucia Anna Muscarella
9661-9671
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer

TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer

https://doi.org/10.18632/oncotarget.23822

Rosana D. Meyer, Xueqing Zou, Marwa Ali, Esma Ersoy, Philip Apraku Bondzie, Mehrdad Lavaei, Ilya Alexandrov, Joel Henderson,  and Nader Rahimi
9672-9684
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation

Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation

https://doi.org/10.18632/oncotarget.23859

Miriam Buttacavoli, Nadia Ninfa Albanese, Gianluca Di Cara, Rosa Alduina, Claudia Faleri, Michele Gallo, Giuseppe Pizzolanti, Giuseppe Gallo, Salvatore Feo, Franco Baldi,  and Patrizia Cancemi
9685-9705
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia

https://doi.org/10.18632/oncotarget.23880

Bhavani Gopalakrishnan, Carolyn Cheney, Rajeswaran Mani, Xiaokui Mo, Donna Bucci, Alison Walker, Rebecca Klisovic, Bhavana Bhatnagar, Katherine Walsh, Bjorn Rueter, Irene Waizenegger, Karl-Heinz Heider, William Blum, Sumithira Vasu,  and Natarajan Muthusamy
9706-9713
Abstract  |  PDF  |  HTML  |  Order a Reprint

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

https://doi.org/10.18632/oncotarget.23882

Guillermo Montalban-Bravo, Koichi Takahashi, Keyur Patel, Feng Wang, Song Xingzhi, Graciela M. Nogueras, Xuelin Huang, Ana Alfonso Pierola, Elias Jabbour, Simona Colla, Irene Gañan-Gomez, Gautham Borthakur, Naval Daver, Zeev Estrov, Tapan Kadia, Naveen Pemmaraju, Farhad Ravandi, Carlos Bueso-Ramos, Ali Chamseddine, Marina Konopleva, Jianhua Zhang, Hagop Kantarjian, Andrew Futreal,  and Guillermo Garcia-Manero
9714-9727
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype

Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype

https://doi.org/10.18632/oncotarget.23887

Karolina Gołąb, Randall Grose, Veronica Placencia, Amittha Wickrema, Julia Solomina, Martin Tibudan, Evelyn Konsur, Kamil Ciepły, Natalia Marek- Trzonkowska, Piotr Trzonkowski, J. Michael Millis, John Fung,  and Piotr Witkowski
9728-9740
Abstract  |  PDF  |  HTML  |  Order a Reprint

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers

https://doi.org/10.18632/oncotarget.24188

Luc Cabel, Alina Fuerea, Ludovic Lacroix, Capucine Baldini, Patricia Martin, Antoine Hollebecque, Sophie Postel-Vinay, Andrea Varga, Rastilav Balheda, Anas Gazzah, Jean-Marie Michot, Aurélien Marabelle, Etienne Rouleau, Eric Solary, Thierry De Baere, Eric Angevin, Jean-Pierre Armand, Stefan Michiels, Jean Yves Scoazec, Samy Ammari, Fabrice André, Jean-Charles Soria, Christophe Massard,  and Loic Verlingue
9741-9750
Abstract  |  PDF  |  HTML  |  Order a Reprint

CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer

CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer

https://doi.org/10.18632/oncotarget.24231

Rosa Mistica C. Ignacio, Yuan-Lin Dong, Syeda M. Kabir, Hyeongjwa Choi, Eun-Sook Lee, Andrew J. Wilson, Alicia Beeghly-Fadiel, Margaret M. Whalen,  and Deok-Soo Son
9751-9765
Abstract  |  PDF  |  HTML  |  Order a Reprint

Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy

Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy

https://doi.org/10.18632/oncotarget.23919

Giuseppe Gritti, Andrea Gianatti, Fiorella Petronzelli, Rita De Santis, Chiara Pavoni, Riccardo Lorenzo Rossi, Laura Cattaneo, Luigi Giusto Spagnoli, Silvia Ferrari, Andrea Rossi, Anna Maria Barbui,  and Alessandro Rambaldi
9766-9775
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model

Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model

https://doi.org/10.18632/oncotarget.24267

Sanghoon Lee, Tishi Shah, Changhong Yin, Jessica Hochberg, Janet Ayello, Erin Morris, Carmella van de Ven,  and Mitchell S. Cairo
9776-9788
Abstract  |  PDF  |  HTML  |  Order a Reprint

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma

https://doi.org/10.18632/oncotarget.23929

Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga,  and Roland Andersson
9789-9807
Abstract  |  PDF  |  HTML  |  Order a Reprint

The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells

The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells

https://doi.org/10.18632/oncotarget.24275

Harrison T. Supnick, Rodica P. Bunaciu,  and Andrew Yen
9808-9824
Abstract  |  PDF  |  HTML  |  Order a Reprint

Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients

Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients

https://doi.org/10.18632/oncotarget.23934

Meng-Hua Lee, Joseph Tung-Chieh Chang, Chun-Ta Liao, Ya-Shan Chen, Ming-Ling Kuo,  and Chia-Rui Shen
9825-9837
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells

Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells

https://doi.org/10.18632/oncotarget.24305

Moritz Horn, Virginia Kroef, Kira Allmeroth, Nicole Schuller, Stephan Miethe, Martin Peifer, Josef M. Penninger, Ulrich Elling,  and Martin S. Denzel
9838-9851
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prominent role of RAB39A-RXRB axis in cancer development and stemness

Prominent role of RAB39A-RXRB axis in cancer development and stemness

https://doi.org/10.18632/oncotarget.23955

Tokuhiro Chano, Hiroko Kita, Sofia Avnet, Silvia Lemma,  and Nicola Baldini
9852-9866
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid

Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid

https://doi.org/10.18632/oncotarget.23984

Birthe Heitkötter, Konrad Steinestel, Marcel Trautmann, Inga Grünewald, Peter Barth, Heidrun Gevensleben, Martin Bögemann, Eva Wardelmann, Wolfgang Hartmann, Kambiz Rahbar,  and Sebastian Huss
9867-9874
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases

https://doi.org/10.18632/oncotarget.23986

Cristina Romei, Raffaele Ciampi, Francesca Casella, Alessia Tacito, Liborio Torregrossa, Clara Ugolini, Fulvio Basolo, Gabriele Materazzi, Paolo Vitti,  and Rossella Elisei
9875-9884
Abstract  |  PDF  |  HTML  |  Order a Reprint

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer

https://doi.org/10.18632/oncotarget.24009

Céléna Dubuc, Martin Savard, Veronica Bovenzi, Andrée Lessard, Audrey Fortier, Jérôme Côté, Witold Neugebauer, Flavio Rizzolio, Sameh Geha, Antonio Giordano, Sylvain Chemtob,  and Fernand Gobeil
9885-9906
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells

Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells

https://doi.org/10.18632/oncotarget.24035

Sumati Gupta, Kelly Doyle, Timothy L. Mosbruger, Andrew Butterfield, Alexis Weston, Allison Ast, Mohan Kaadige, Anupam Verma,  and Sunil Sharma
9907-9924
Abstract  |  PDF  |  HTML  |  Order a Reprint

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice

https://doi.org/10.18632/oncotarget.24066

Shoji Yamada, Yoko Takashina, Mitsuhiro Watanabe, Ryogo Nagamine, Yoshimasa Saito, Nobuhiko Kamada,  and Hidetsugu Saito
9925-9939
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

CXCR4: A new player in vestibular schwannoma pathogenesis

CXCR4: A new player in vestibular schwannoma pathogenesis

https://doi.org/10.18632/oncotarget.24119

Maria Breun, Alexandra Schwerdtfeger, Donato Daniel Martellotta, Almuth F. Kessler, Jose M. Perez, Camelia M Monoranu, Ralf-Ingo Ernestus, Cordula Matthies, Mario Löhr,  and Carsten Hagemann
9940-9950
Abstract  |  PDF  |  HTML  |  Order a Reprint

Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation

Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation

https://doi.org/10.18632/oncotarget.24131

Hyun-Kyung Kim, Purevjargal Naidansuren, Seung Woo Lee, Rae-Kwon Kim, Su-Jae Lee, Suk Keun Lee, Yong-Kil Hong,  and Young Ae Joe
9951-9962
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway

HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway

https://doi.org/10.18632/oncotarget.24133

Xi Xu, Yunfeng Wang, Hong Deng, Chungang Liu, Jingjing Wu,  and Maode Lai
9963-9974
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits

Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits

https://doi.org/10.18632/oncotarget.24160

Takashi Yoshida, Masaki Ri, Takashi Kanamori, Sho Aoki, Reham Ashour, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shun Kitahata, Takuya Chiba, Satoshi Ichikawa,  and Shinsuke Iida
9975-9991
Abstract  |  PDF  |  HTML  |  Order a Reprint

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma

https://doi.org/10.18632/oncotarget.24173

Yanming Jiang, Song Qu, Xinbin Pan, Shiting Huang,  and Xiaodong Zhu
9992-10004
Abstract  |  PDF  |  HTML  |  Order a Reprint

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study

https://doi.org/10.18632/oncotarget.24234

Stéphane Supiot, Caroline Rousseau, Mélanie Dore, Catherine Cheze-Le-Rest, Christine Kandel-Aznar, Vincent Potiron, Stéphane Guerif, François Paris, Ludovic Ferrer, Loïc Campion, Philippe Meingan, Gregory Delpon, Matthieu Hatt,  and Dimitris Visvikis
10005-10015
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell

Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell

https://doi.org/10.18632/oncotarget.24245

Yuan-Hao Chen, Tung-Tai Kuo, Eagle Yi-Kung Huang, Yu-Ching Chou, Yung-Hsiao Chiang, Barry J. Hoffer,  and Jonathon Miller
10016-10028
Abstract  |  PDF  |  HTML  |  Order a Reprint

CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells

CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells

https://doi.org/10.18632/oncotarget.24252

Hiroaki Miyazaki, Ryou-u Takahashi, Marta Prieto-Vila, Yumi Kawamura, Seiji Kondo, Tatsuo Shirota,  and Takahiro Ochiya
10029-10041
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Mutational landscape of radiation-associated angiosarcoma of the breast

Mutational landscape of radiation-associated angiosarcoma of the breast

https://doi.org/10.18632/oncotarget.24273

Bryan J. Thibodeau, Vincent Lavergne, Nayana Dekhne, Pamela Benitez, Mitual Amin, Samreen Ahmed, Jean L. Nakamura, Philip R. Davidson, Alice O. Nakamura, Inga S. Grills, Peter Y. Chen, Jessica Wobb,  and George D. Wilson
10042-10053
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.24300

Nataliya Rohr-Udilova, Eva Bauer, Gerald Timelthaler, Robert Eferl, Klaus Stolze, Matthias Pinter, Martha Seif, Hubert Hayden, Thomas Reiberger, Rolf Schulte-Hermann, Markus Peck-Radosavljevic, Dagmar Stoiber,  and Michael Trauner
10054-10068
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain

Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain

https://doi.org/10.18632/oncotarget.24311

Anna Kovalchuk, Yaroslav Ilnytskyy, Rafal Woycicki, Rocio Rodriguez-Juarez, Gerlinde A.S. Metz,  and Olga Kovalchuk
10069-10082
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Meta-Analysis

Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis

Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis

https://doi.org/10.18632/oncotarget.23394

Yong Ding, Hai-Feng Lian,  and Yaowu Du
10083-10090
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical Research Papers

Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications

Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications

https://doi.org/10.18632/oncotarget.23497

Dong Ni, Xin Ma, Hong-Zhao Li, Yu Gao, Xin-Tao Li, Yu Zhang, Qing Ai, Qing-Bo Huang, Jun-Yao Duan,  and Xu Zhang
10091-10099
Abstract  |  PDF  |  HTML  |  Order a Reprint

Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer

Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer

https://doi.org/10.18632/oncotarget.24071

Yingqiu Song, Beth Erickson, Xiaojian Chen, Guiling Li, Gang Wu, Eric Paulson, Paul Knechtges,  and Li X. Allen
10100-10109
Abstract  |  PDF  |  HTML  |  Order a Reprint

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer

https://doi.org/10.18632/oncotarget.24118

Hatem Soliman, Fatema Khambati, Hyo S. Han, Roohi Ismail-Khan, Marilyn M. Bui, Daniel M. Sullivan,  and Scott Antonia
10110-10117
Abstract  |  PDF  |  HTML  |  Order a Reprint

Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients

Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients

https://doi.org/10.18632/oncotarget.24076

Zhouxiang Jin, Shujuan Zhou, Haige Ye, Songfu Jiang, Kang Yu,  and Yang Ji
10118-10127
Abstract  |  PDF  |  HTML  |  Order a Reprint

18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer

18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer

https://doi.org/10.18632/oncotarget.24176

Hinrich Wieder, Ambros J. Beer, Jens Siveke, Tibor Schuster, Andreas K. Buck, Ken Herrmann,  and Jens C. Stollfuss
10128-10134
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

Metformin and berberine, two versatile drugs in treatment of common metabolic diseases

Metformin and berberine, two versatile drugs in treatment of common metabolic diseases

https://doi.org/10.18632/oncotarget.20807

Haoran Wang, Chen Zhu, Ying Ying, Lingyu Luo, Deqiang Huang,  and Zhijun Luo
10135-10146
Abstract  |  PDF  |  HTML  |  Order a Reprint

Newly developed anti-angiogenic therapy in non-small cell lung cancer

Newly developed anti-angiogenic therapy in non-small cell lung cancer

https://doi.org/10.18632/oncotarget.23755

Jingjing Qu, Yongchang Zhang, Xue Chen, Haiyan Yang, Chunhua Zhou,  and Nong Yang
10147-10163
Abstract  |  PDF  |  HTML  |  Order a Reprint

The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer

The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer

https://doi.org/10.18632/oncotarget.24309

Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, Bimal Kumar Sarkar,  and Sang-Soo Lee
10164-10174
Abstract  |  PDF  |  HTML  |  Order a Reprint

Case Reports

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression

https://doi.org/10.18632/oncotarget.23699

Gregorio J. Petrirena, Julien Masliah-Planchon, Quentin Sala, Bertrand Pourroy, Didier Frappaz, Emeline Tabouret, Thomas Graillon, Jean-Claude Gentet, Olivier Delattre, Olivier Chinot,  and Laetitia Padovani
10175-10183
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy

Correction: Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy

https://doi.org/10.18632/oncotarget.24463

Sheng-Chieh Chan, Nai-Ming Cheng, Chia-Hsun Hsieh, Shu-Hang Ng, Chien-Yu Lin, Tzu-Chen Yen, Cheng-Lung Hsu, Hung-Ming Wan, Chun-Ta Liao, Kai-Ping Chang,  and Jiun-Jie Wang
10184-10184
Correction  |  PDF


Copyright © 2018 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC